Small Cell Lung Cancer and Neuroendocrine Carcinoma research hub

A study to evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and preliminary Anti-Tumor activity of RO7616789 in participants with Advanced Small Cell Lung Cancer and other Neuroendocrine Carcinomas

This study is testing a new medicine, RO7616789, for people with advanced lung and other rare cancers called neuroendocrine carcinomas. Researchers want to see if it's safe, how it works in the body, and if it can help fight the cancer. It's an early-stage study.